findmyKOL

Jack Arbiser, MD

Basic profile

Emory University

ORCID↗NPI↗
✓ Full record
RegionAtlanta, GA · SoutheastSpecialtyDermatologyFocusDermatology
Active KOLfindmyKOL type: NationalLatest publication2023Online presenceNot yet checkedPayments2021 onwardNIH funding1997–2022

Jack Arbiser is a Dermatology physician affiliated with Emory University. OpenAlex indexes 446 publications with 18,141 citations (h-index 72). By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
446publications

Distinct works indexed by OpenAlex, matched via ORCID.

18,141citations

Total citations across indexed works.

72h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
13companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
8NIH grants · 1997–2022

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1365 Clifton Rd NE
Department Of Dermatology
Atlanta, GA 303221013

Telephone

404-727-5063

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Industry payments

13 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Dermatology

    33.4%
    alpha-Hydroxy Acid18%
    Ammonium Lactate100%
    Part D≥92 patients
    Corticosteroid12.5%
    Triamcinolone Acetonide100%
    Part D≥65 patients

    + 2 more classes in this area

  • Respiratory

    22.2%
    Leukotriene Receptor Antagonist17.8%
    Montelukast Sodium100%
    Part D≥64 patients
    RNA Synthetase Inhibitor Antibacterial4.5%
    Mupirocin100%
    Part D≥27 patients
  • Sensory organs

    15.8%
    Corticosteroid15.8%
    Clobetasol Propionate100%
    Part D≥71 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

8 NIH research awards on record, funded 1997–2022 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”